Use of Three‐Compartment Physiologically Based Pharmacokinetic Modeling to Predict Hepatic Blood Levels of Fluvoxamine Relevant for Drug–Drug Interactions

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 4, 2015-04 ,pp. : 1478-1491

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug–drug plasma protein binding interactions of ivacaftor

By  

JOURNAL OF MOLECULAR RECOGNITION (ELECTRONIC), Vol. 28, Iss. 6, 2015-06 ,pp. : 339-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug–Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 3183-3193

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter‐Based Drug–Drug Interactions in a Clinical Setting—Proposal of a Four Component Transporter Cocktail

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 3220-3228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Scaling In Vivo Pharmacokinetics from In Vitro Metabolic Stability Data in Drug Discovery

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 13, Iss. 2, 2010-02 ,pp. : 159-169

Bentham Science Publishers

Access to resources Recommend Favorite